Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BF.7.26EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BF.7.26EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BR.1.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BR.1.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.1.25EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.1.25EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.1.51EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.1.51EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.4.7EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.4.7EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.29EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.29EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.38EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.38EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.2.40EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.2.40EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.160.25EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.160.25EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FK.1.4.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FK.1.4.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.13EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.13EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
DR.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
DR.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.160.15EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.160.15EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.219EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.219EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
N.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
N.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.208EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.208EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.125.1 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.125.1 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.78 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.78 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.159EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.159EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.43.5 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.43.5 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBC.1.6.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBC.1.6.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.366EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.366EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.441EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.441EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.416EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.416EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.63EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.63EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used